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Young mice treated with Toximul MP8, a polyoxyethylene ether based emulsifier, show an increased mortality when infected with encephalomyocarditis virus (EMC) than do control mice. Lymphocytes taken from these emulsifier treated mice respond poorly to interferon induction, as compared to controls. Interferon also protects control mice against EMC infection but such protection is reduced in emulsifier-treated mice. This enhanced lethality to EMC in emulsifier-treated mice may be due to compromised interferon response in these animals.
Blood samples were obtained from a group of Reye's patients in the acute and convalescent phase of their disease. Lymphocytes were induced to synthesize interferon by Newcastle Disease Virus. Peripheral blood lymphocytes from convalescent patients and controls responded well to interferon induction. Lymphocytes taken in the acute phase of children with Reye's syndrome produced significantly less interferon than those from recovering patients or controls. Since eye's syndrome is an unusual response on the part of the host following a virus infection our data would appear to implicate interferon as part of this altered response. Urines were obtained from myelomeningocele patients with intact urinary tracts and by double lumen catheterization from myelomeningocele patients with ileal conduit urinary tract diversions. Urines were subjected to quantitative culture, LDH isoenzyme analysis, lysozyme concentration measurement, and testing for antibody coated bacteria. Individuals with anatomically intact urinary tracts and < lo5 organisms per ml of urine had virtually no positive results by the three ancillary assays. Individuals with ileal conduits and <lo5 organisms per ml of urine had normal lysozyme levels and negative antibody coating tests, but the majority had positive LDH isoenzyme assays. When > lo5 organisms were present, individuals with ileal conduits were more likely to have positive results by all three assays than were those with intact urinary anatomy. Among patients with ileal conduits, changes in LDH isoenzyme positivity did not correlate with bacteriuria symptoms or antibiotic therapy.
DEVELOPMENT OF MENINGITIS FOLLOWING LUMBAR PUNCTURE
As judged by lysozymuria and testing for antibody coated bacteria, > lo5 bacteria per ml appears to represent significant bacteriuria in patients with ileal conduit urinary diversion. Lysozymuria and antibody coating of urinary bacteria may be useful in identifying patients with ileal conduit diversions whoare. at risk for chronic pyelonephritis. Methicillin (M), nafcillin (N) and oxacillin (Ox) are commonly used antimicrobial agents, but limited prospective data are available about the incidence of their side effects in pediatric patients. Sixty-nine patients (newborn-18 yr) were evaluated prospectively for adverse effects associated with M, N or Ox. Hematologic parameters (hemoglobin, hematocrit, WBC with diff, platelet ct, and reticulocyte ct), hepatic enzymes (SGOT, SGPT) and renal function tests (BUN, serum creatinine and urinalysis) were obtained before the institution of treatment and at frequent intervals (min every 5 d) during the course of therapy. Culture and sensitivity, daily body temp and concomitant drugs were recorded. Three of 28 patients receiving M developed eosinophilia (eos, 705-1547/cu mm) within 5-8 days of therapy. Of 32 patients on N, 2 developed neutropenia (neut, 642-7521cu mm) within 4-13 days of therapy; 3 developed eosinophilia (eos, 1030-2171Icu mm) within 1-4 days of therapy; and 1 developed elevation of liver enzymes (SGOT 179 RFU, SGPT 98 RFU) on day 3 of treatment. Of 9 patients receiving Ox, 1 developed elevation of liver enzymes (SGOT 158 RFU, SGPT 409 RFU) on day 15, and 1 developed neutropenia (neut 684bcu mm) on day 11 of therapy. All laboratory values returned to normal with the discontinuation of therapy. Our data suggest that appropriate laboratory tests should be monitored to detect occurrence of adverse effects to M, N and Ox. The occurrence of breast abscesses has not previously been studied in an adolescent female population. We identified 12 patients at our institution over the past 4 years with breast abscesses. The patients ranged in age from 12 to 19 years and were all post-pubertal. None of the patients were menstruating at the time of presentation, nor were any post-partum or breast feeding. Only 3 patients were febrile; all were treated with antibiotics and 11 required surgical drainage. The infections were caused by Staphylococcus aureus in 7 patients, Staphylococcus epidermidis in 1, mixed anaerobes in 2, and both Group B Streptococcus and Staph epidermidis in 1. Ten of the 12 abscesses were subareolar. Both patients with anaerobic infections had several recurrences and required surgical excision of breast tissue. The anaerobic organisms identified were typical of normal oral flora. Our data indicate that (1) breast abscesses are not rare in the non-puerperal adolescent female and (2) anaerobes are important pathogens in this disorder and result in greater morbidity than breast abscesses due to staphylococci. This study demonstrates the need for anaerobic as well as aerobic culturing of breast abscesses and antibiotic and surgical management based on etiologic agents. Group B streptococci (GBS) are a major cause of sepsis and meningitis in the e r n . Neonatal susceptibility to GBS infection appears to be associated with a deficiency of opsonic antibody to GBS. The present studies were designed to determine if human antibodies protective for one type I11 GBS strain provide uniform protection for other type I11 strains. IgG was affinity purified £ran pooled hurran innnunoglobulin using a staphylococcal protein A imwncabsorbant. The relative titers of IgG antibdies to g m u p B and type I11 (native and core) antigenswxe determined. To evaluate protection, suckling rats were challenged S.Q. with each of 4 different clinical isolates of GBS type I11 f o l l d inediately by various concentrations of purified IgG given IP. With 5 or 10 pg of IgG significant survival m r e d in animals challenged with one strain (17/20, 85%), whereas this arrountof antibody afforded no protection against the other 3 strains (0/27). Administration of 20 !Jg of IgG provided sane protection for 2 of these strains (7/23, 3/9), but uniform lethality occurred with the fourth strain even when m r e than 40 ug IgG was given. These studies demonstrate that four type I11 cBS strains require different arrounts of h m n IgG for protection. Strain variability must be examined in future investigations of vaccine induced or passively acquired IgG for protection against GBS disease.
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